Project Grant W81XWH2210655
Award Date
7/15/22
Completion Date
7/14/26
Dollars Obligated
$1.7M
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Children's Hospital of Philadelphia was awarded a $2,186,587 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund observational cohort studies at The Children's Hospital of Philadelphia and sub-awardees The University of Texas M.D. Anderson Cancer Center, University of California San Francisco, Baylor College of Medicine, and Seattle Children's Hospital from July 2022 through...
The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic...
This $1,746,810.00 federal Project Grant award was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by The Children's Hospital of Philadelphia (CHOP) to develop combination therapy approaches for treating high-risk, MYCN-amplified neuroblastoma, a type of pediatric cancer. The research project will run from July 1, 2025 to June 30, 2028. As a leading pediatric healthcare...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $356,000.00 to The Children's Hospital of Philadelphia (CHOP) to study the impact on ketosis phenotype. The performance period for this award is from Sep 1, 2024 to Aug 31, 2026. As a leading pediatric research institution, CHOP leverages its expertise in areas such as genetic disorders and neurological conditions to contribute to...
The U.S. Defense Health Agency awarded a $1,751,725 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME" from September 1, 2023 to August 31, 2027. CHOP, a pediatric hospital and research center, will use this funding from the Military Medical Research and Development program (CFDA 12.420) to transform health care for Service Members and the American public through innovative and impactful...
The Children's Hospital of Philadelphia was awarded a $23.7 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will support the development and clinical validation of noninvasive diagnostics for mitochondrial disease from 2022 through 2026. Through this funding, the awardee will work to transform healthcare for service members and the public by investigating medical solutions for the...
This $356,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a novel gene therapy for mitochondrial complex I deficiency at the Children's Hospital of Philadelphia (CHOP). The award period runs from March 1, 2024 to February 28, 2026. CHOP, a leading pediatric hospital and research institution, will leverage its expertise in areas like rare genetic disorders to advance this innovative...
The Department of the Army Medical Command awarded a $2,247,531 project grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program (CFDA 12.420) to conduct a comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma. The four-year project beginning September 1, 2022 will apply basic, applied, and advanced biomedical research approaches to transform pediatric cancer care and investigate...
This $152,761 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a research study at The Children's Hospital of Philadelphia (CHOP) investigating the use of quantitative sodium magnetic resonance imaging (MRI) and chemical exchange saturation transfer (CEST) to analyze low-grade gliomas in children with neurofibromatosis type 1. The 2-year study, which commenced on September 15, 2023, aims to advance diagnostic...